Delivery Order SPE2DE24DA017-SPE2D625F2D2W

Award Date 4/9/25
Potential Completion Date 4/14/25
Potential Value $1.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Naples, FL 34108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $1,584.00, is a Fixed Price Delivery Order with Economic Price Adjustment for the purchase of the ACP MAX PRP SYSTEM (OUS/EU). This award is not associated with a set-aside program. Arthrex, a for-profit Subchapter S Corporation headquartered in Naples, Florida, has a...
This is a federal contract award to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures, by the Defense Logistics Agency (DLA). The contract is for the procurement of the ACP MAX PRP SYSTEM (W/ ACDA), a specialized orthopedic product. The fixed-price contract with economic price adjustment has a ceiling value of $1,514.70 and a period of performance through September 10, 2024. Arthrex, a for-profit Subchapter S Corporation based in Naples, Florida, has received...
This federal contract award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $1,514.70, is for the delivery of the "4566415286 ! ACP MAX PRP SYSTEM (W/ ACDA)" product. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type and an Ultimate Completion Date of November 18, 2024. This contract award is not...
This federal contract award, identified as SPE2DE24DA017|SPE2D625F34YT, was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The $1,127.94 fixed-price with economic price adjustment delivery order contract is for the procurement of the ACP MAX PRP SYSTEM (W/ ACDA), a specialized orthopedic medical product. Arthrex, a for-profit Subchapter S Corporation, has demonstrated extensive capabilities...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $3,633.30, is a Delivery Order for an "ACP MAX PRP SYSTEM (W/ ACDA)" and has a fixed price with economic price adjustment pricing type. The contract has an ultimate completion date of January 14, 2025 and was awarded on January 9, 2025. The contract was not designated as a...
This is a delivery order contract awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract is for the ACP MAX PRP SYSTEM (OUS/EU), a medical device used in orthopedic procedures, with a ceiling value of $15,759.00. The contract is a Fixed Price with Economic Price Adjustment, with a period of performance through March 6, 2025. Arthrex Inc. is a for-profit Subchapter S Corporation...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $7,573.50 fixed-price delivery order is for the 4566485933 ACP MAX PRP SYSTEM (W/ ACDA), with a period of performance ending on November 22, 2024. Arthrex, a for-profit Subchapter S Corporation, has a robust portfolio of orthopedic medical products, including surgical implants, arthroscopic...
This federal contract award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $1,650.00 fixed-price with economic price adjustment delivery order is for the Arthrex ACP Double Syringe System, a specialized medical device used for orthopedic procedures. The contract has an ultimate completion date of December 27, 2024. Arthrex, a for-profit Subchapter S Corporation headquartered in...
This federal contract award, valued at $2,475.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract is for the delivery of the Arthrex ACP Double Syringe System, a specialized medical device used in orthopedic procedures. The contract has an ultimate completion date of January 8, 2025 and is a Delivery Order with a Fixed Price with Economic Price...
This federal contract award was issued by the Defense Logistics Agency's Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The contract, valued at $18,961.99, is for the delivery of Arthrex's ACP Double Syringe System, a specialized medical device used in orthopedic procedures. This is a Fixed Price with Economic Price Adjustment contract with a completion date of December 16, 2024. The contract is not designated as a set-aside....
  • SPE2DE24DA017
    Indefinite Delivery Contract
  • SPE2DE24DA017-SPE2D625F2D2W
    Delivery Order

This federal contract award, identified as SPE2DE24DA017|SPE2D625F2D2W, was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies. The contract is a Delivery Order with a fixed price and economic price adjustment, valued at $1,163.58, and has an ultimate completion date of April 14, 2025.

The contract covers the procurement of the ACP MAX PRP SYSTEM (W/ ACDA), a specialized medical device used in orthopedic procedures. Arthrex, a for-profit Subchapter S Corporation based in Naples, Florida, has demonstrated extensive capabilities in providing innovative orthopedic medical products and technologies to government healthcare systems, particularly the Department of Veterans Affairs (VA) and the Department of Defense (DoD). This contract award is not a set-aside, indicating Arthrex's strong competitive position in the federal market. Additionally, Arthrex holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $471,048,172.66, which allows VA medical centers nationwide to acquire Arthrex's orthopedic solutions through task orders.

Generated 7/9/25, 9:56 AM